pipette
ESEspañol

Dynamic nanocomplexes of antibiotics and biofilm-degrading enzymes overcome biofilm tolerance to treat Pseudomonas aeruginosa infections

A. Yourdkhani, N. Y. Brittain, C. Nwagwu, J. H. Lee, J. Cao, S. Jamshid-Nezhad, J. A. Finbloom

PreprintReal-world use

In the authors' words

Pseudomonas aeruginosa biofilms limit antibiotic penetration and protect embedded bacteria, making established infections difficult to treat. To combat the biofilm, administering tobramycin (Tob) with deoxyribonuclease I (DNase) could pair antimicrobial action with biofilm matrix degradation, but their distinct physicochemical properties hinder co-delivery and transport into the biofilm core. Taking advantage of the acidic biofilm microenvironment, we developed pH-responsive nanocomplexes (NCs) that expand, favoring local retention of the NCs and their cargo. We used stepwise electrostatic precomplexation to co-load Tob and DNase into the NCs, then electrostatically added a PEG-bearing polymer to their surface to improve NC distribution within biofilms, forming PEG-NCs. Across established biofilms of three P. aeruginosa strains, these dynamic NCs overcame biofilm-associated tolerance toward tobramycin and produced the most consistent reductions in bacterial burden and biomass. Formulation-function analyses coupled with biofilm imaging suggested complementary contributions from PEG and active DNase components. In an established murine abscess model, a single intra-abscess PEG-NC injection reduced bacterial burden by approximately 2 log-fold and improved abscess healing, whereas dose-matched Tob and Tob+DNase controls did not significantly improve infection outcomes. Overall, dynamic NCs mediate the co-delivery of biofilm matrix disruptors with antibiotics to improve treatment of established biofilm infections.

Main resultThe abstract does not state a limitation.

Appeared: Thursday, November 19. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.16.767167